LINDSAY GAMBLE: Open Payments
NPI 1720636475 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,535 in 132 payments from 24 companies in 2025. Trend: 2023 $2,667 · 2024 $2,584 · 2025 $2,535
Food & beverage: $2,501Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $701 |
| GlaxoSmithKline, LLC. | 33 | $320 |
| GENZYME CORPORATION | 7 | $207 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $179 |
| Amgen Inc. | 12 | $172 |
| Novo Nordisk Inc | 6 | $110 |
| Verona Pharma, Inc. | 5 | $105 |
| Grifols USA, LLC | 4 | $85 |
| Electromed, Inc. | 7 | $77 |
| United Therapeutics Corporation | 4 | $72 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, BREZTRI, TRELEGY ELLIPTA, OFEV, FASENRA, Ohtuvayre.
Industry payments across IN — which companies pay providers there.
